Flatiron Health Expands Oncology Network with First Scottish Partnership — Flatiron Health, Inc.

Event summary

Flatiron Health partners with NHS Greater Glasgow and Clyde, its first collaboration in Scotland.
The partnership expands Flatiron’s international oncology network to over 50 sites across the UK, Germany, and Japan.
Flatiron’s ex-US network has grown nearly 70% in the last year, now including patient records from more than six million patients globally.

The big picture

Flatiron Health’s expansion into Scotland underscores the growing demand for high-quality, geographically diverse oncology data. The partnership aligns with broader industry trends toward leveraging real-world evidence to inform regulatory and commercial decisions in cancer care. With strategic backing from Roche Group, Flatiron is positioning itself as a key player in global oncology research.

What we're watching

Data Quality and Compliance: How Flatiron maintains consistent data quality standards while adapting to different healthcare systems.
Regulatory Influence: Whether the expanded global dataset will accelerate regulatory decisions for oncology treatments.
Market Expansion: The pace at which Flatiron can integrate additional international healthcare systems into its network.